Results of the CPTAC data showed that TRMT112 proteins in colon cancer, ovarian cancer, and clear cell renal cell carcinoma samples were more abundant relative to that in the respective normal control (Figure 1(c), P < 0.001). The gene discussed is TRMT112; the disease is malignant colon neoplasm.